The DABOM

Seoul, South Korea Founded: 2021 • Age: 5 yrs
Produces artificial exosomes for medical applications via advanced platforms.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About The DABOM

The DABOM is a company based in Seoul (South Korea) founded in 2021. It operates as a B2B and SaaS. The DABOM offers products and services including Exocure TM and Exostation TM. The DABOM operates in a competitive market with competitors including Biological Dynamics, Sirnaomics, Acorda, Liquidia and Genedit, among others.

  • Headquarter Seoul, South Korea
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name 주식회사 더다봄
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of The DABOM

The DABOM offers a comprehensive portfolio of products and services, including Exocure TM and Exostation TM.

Primary

Artificial exosomes for therapeutic medical applications.

System for mass-producing artificial exosomes using AI.

Funding Insights of The DABOM

Investments & Acquisitions by The DABOM

Investments

Financial Statements - The DABOM

The Dabom Comparisons

+
Add Comparison
Available on Premium

Competitors of The DABOM

The DABOM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Sirnaomics, Acorda, Liquidia and Genedit, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
domain founded_year HQ Location
RNA-based therapeutics for cancer and fibrosis are developed.
domain founded_year HQ Location
Engaged in the development and commercialization of therapies that improve neurological function.
domain founded_year HQ Location
Engineered particles & films for life and material sciences applications
domain founded_year HQ Location
Genetic medicines are delivered using polymer nanoparticle platforms.
domain founded_year HQ Location
Drug delivery systems to cell interiors are developed via nanosyringes.

Latest news on The Dabom

Frequently Asked Questions about The DABOM

The DABOM was founded in 2021.

The DABOM is headquartered in Seoul, South Korea.

The DABOM is a South Korean company that utilizes microfluidics and artificial intelligence to mass-produce artificial exosomes for nanomedicine. They offer platforms like Exocure TM for therapeutics and Exostation TM for production, focusing on RD and partnerships. Based in Seoul, they participate in conferences and collaborate with institutions for exosome-based innovations, advancing healthcare technology.

The DABOM's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.

The DABOM offers Exocure TM and Exostation TM.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available